Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Rowinsky

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Seminars in Oncology|June 1, 1995
Intraperitoneal paclitaxel: a possible role in the management of ovarian cancer?M Markman, P Francis, E Rowinsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
Phase I feasibility and pharmacologic study of weekly intraperitoneal paclitaxel: a Gynecologic Oncology Group pilot StudyP Francis, E Rowinsky, J Schneider, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2000
Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trialP Bonomi, K Kim, D Fairclough, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 1997
Preirradiation paclitaxel in glioblastoma multiforme: efficacy, pharmacology, and drug interactions. New Approaches to Brain Tumor Therapy Central Nervous System ConsortiumM R Fetell, S A Grossman, J D Fisher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Phase III comparison of high-dose paclitaxel + cisplatin + granulocyte colony-stimulating factor versus low-dose paclitaxel + cisplatin in advanced head and neck cancer: Eastern Cooperative Oncology Group Study E1393A A Forastiere, T Leong, E Rowinsky, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1993
A reassessment of cardiac toxicity associated with TaxolS G Arbuck, H Strauss, E Rowinsky, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1993
Intraperitoneal administration of Taxol in the management of ovarian cancerM Markman, E Rowinsky, T Hakes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 1992
Phase I trial of intraperitoneal taxol: a Gynecoloic Oncology Group studyM Markman, E Rowinsky, T Hakes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Intraperitoneal Taxol (paclitaxel) in the management of ovarian cancerM Markman, P Francis, E Rowinsky, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2000
Phase II study of the multitargeted antifolate LY231514 (ALIMTA, MTA, pemetrexed disodium) in patients with advanced pancreatic cancerK D Miller, J Picus, C Blanke, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Seminars in Oncology|June 1, 1995
Intraperitoneal paclitaxel: a possible role in the management of ovarian cancer?M Markman, P Francis, E Rowinsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
Phase I feasibility and pharmacologic study of weekly intraperitoneal paclitaxel: a Gynecologic Oncology Group pilot StudyP Francis, E Rowinsky, J Schneider, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2000
Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trialP Bonomi, K Kim, D Fairclough, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 1997
Preirradiation paclitaxel in glioblastoma multiforme: efficacy, pharmacology, and drug interactions. New Approaches to Brain Tumor Therapy Central Nervous System ConsortiumM R Fetell, S A Grossman, J D Fisher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Phase III comparison of high-dose paclitaxel + cisplatin + granulocyte colony-stimulating factor versus low-dose paclitaxel + cisplatin in advanced head and neck cancer: Eastern Cooperative Oncology Group Study E1393A A Forastiere, T Leong, E Rowinsky, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1993
A reassessment of cardiac toxicity associated with TaxolS G Arbuck, H Strauss, E Rowinsky, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1993
Intraperitoneal administration of Taxol in the management of ovarian cancerM Markman, E Rowinsky, T Hakes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 1992
Phase I trial of intraperitoneal taxol: a Gynecoloic Oncology Group studyM Markman, E Rowinsky, T Hakes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Intraperitoneal Taxol (paclitaxel) in the management of ovarian cancerM Markman, P Francis, E Rowinsky, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2000
Phase II study of the multitargeted antifolate LY231514 (ALIMTA, MTA, pemetrexed disodium) in patients with advanced pancreatic cancerK D Miller, J Picus, C Blanke, et al.
Pageof 2